1. Home
  2. BGLC vs RVYL Comparison

BGLC vs RVYL Comparison

Compare BGLC & RVYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGLC
  • RVYL
  • Stock Information
  • Founded
  • BGLC N/A
  • RVYL 2007
  • Country
  • BGLC Malaysia
  • RVYL United States
  • Employees
  • BGLC 30
  • RVYL N/A
  • Industry
  • BGLC Medical Specialities
  • RVYL Professional Services
  • Sector
  • BGLC Health Care
  • RVYL Consumer Discretionary
  • Exchange
  • BGLC Nasdaq
  • RVYL Nasdaq
  • Market Cap
  • BGLC 9.2M
  • RVYL 13.7M
  • IPO Year
  • BGLC N/A
  • RVYL N/A
  • Fundamental
  • Price
  • BGLC $0.51
  • RVYL $2.02
  • Analyst Decision
  • BGLC
  • RVYL Hold
  • Analyst Count
  • BGLC 0
  • RVYL 1
  • Target Price
  • BGLC N/A
  • RVYL N/A
  • AVG Volume (30 Days)
  • BGLC N/A
  • RVYL 46.0K
  • Earning Date
  • BGLC N/A
  • RVYL 08-12-2024
  • Dividend Yield
  • BGLC N/A
  • RVYL N/A
  • EPS Growth
  • BGLC N/A
  • RVYL N/A
  • EPS
  • BGLC N/A
  • RVYL N/A
  • Revenue
  • BGLC N/A
  • RVYL $71,352,000.00
  • Revenue This Year
  • BGLC N/A
  • RVYL $31.47
  • Revenue Next Year
  • BGLC N/A
  • RVYL N/A
  • P/E Ratio
  • BGLC N/A
  • RVYL N/A
  • Revenue Growth
  • BGLC N/A
  • RVYL 78.42
  • 52 Week Low
  • BGLC N/A
  • RVYL $1.12
  • 52 Week High
  • BGLC N/A
  • RVYL $17.50
  • Technical
  • Relative Strength Index (RSI)
  • BGLC 53.92
  • RVYL 59.42
  • Support Level
  • BGLC $0.46
  • RVYL $1.95
  • Resistance Level
  • BGLC $0.55
  • RVYL $2.25
  • Average True Range (ATR)
  • BGLC 0.03
  • RVYL 0.21
  • MACD
  • BGLC 0.01
  • RVYL 0.04
  • Stochastic Oscillator
  • BGLC 57.89
  • RVYL 63.28

About BGLC BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.

About RVYL Ryvyl Inc.

Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.

Share on Social Networks: